TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial.
Br J Cancer
; 113(5): 722-8, 2015 Sep 01.
Article
in En
| MEDLINE
| ID: mdl-26284338
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Bridged-Ring Compounds
/
Biomarkers, Tumor
/
Taxoids
/
Co-Repressor Proteins
/
Neoplasm Recurrence, Local
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Br J Cancer
Year:
2015
Document type:
Article
Affiliation country:
Canadá
Country of publication:
Reino Unido